{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:38:36Z","timestamp":1791308316467,"version":"4.3.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"DOI":"10.1097\/qai.0b013e31829a2f12","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T15:01:15Z","timestamp":1368543675000},"page":"149-153","source":"Crossref","is-referenced-by-count":49,"title":["Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1\u2013Infected Individuals"],"prefix":"10.1097","volume":"64","author":[{"given":"Mar\u00eda","family":"Abad-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Hern\u00e1ndez-Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/157016211795945296","article-title":"G, Paiardini M, Zaffiri L, et al.. HIV persistence in the gut mucosa of HIV-infected subjects undergoing antirretroviral therapy correlates with immune activation and increased levels of LPS.","volume":"9","year":"2011","journal-title":"Curr HIV Res"},{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/QAD.0b013e32833b254d","article-title":". Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.","volume":"24","author":"Toseid","year":"2010","journal-title":"AIDS"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/INF.0b013e31821d141e","article-title":". Increased microbial translocation in 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.","volume":"30","author":"Papasavvas","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V92.6.2084.418k26_2084_2092","article-title":". Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events.","volume":"92","author":"Lien","year":"1998","journal-title":"Blood"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"e1001052","DOI":"10.1371\/journal.ppat.1001052","article-title":". Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infection.","volume":"6","author":"Estes","year":"2010","journal-title":"PLoS Pathog"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":". Microbial translocation is a cause of systemic immune activation in chronic HIV infection.","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0b013e3283112d29","article-title":". Microbial translocation is associated with sustained failure in CD4 T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.","volume":"22","author":"Marchetti","year":"2008","journal-title":"AIDS"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00002030-200404300-00005","article-title":". Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.","volume":"18","author":"Karlsson","year":"2004","journal-title":"AIDS"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":". The challenge of finding a cure for HIV infection.","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":". Immune activation set point during early HIV infection predicts subsequent CD4 T-cell changes independent of viral load.","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":". Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clim.2006.04.570","article-title":". Low CD4 T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4 T-cell activation and senescence but not with lower effector memory T-cell function.","volume":"120","author":"Fernandez","year":"2006","journal-title":"Clin Immunol"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":". T cell activation is associated with lower CD4 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":". CD4 count and risk of non-AIDS diseases following initial treatment for HIV infection.","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":". Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.","volume":"106","author":"Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/650749","article-title":". Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.","volume":"50","author":"McMahon","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","article-title":". Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.","volume":"24","author":"Yukl","year":"2010","journal-title":"AIDS"},{"key":"R18-6-20210131","doi-asserted-by":"crossref","first-page":"e27864","DOI":"10.1371\/journal.pone.0027864","article-title":". Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: Effect on T cells latently infected.","volume":"6","author":"Gutierrez","year":"2011","journal-title":"PLos One"},{"key":"R19-6-20210131","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/QAD.0b013e3283584521","article-title":". The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.","volume":"26","author":"Vallejo","year":"2012","journal-title":"AIDS"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/09680519050110040701","article-title":"Modulatory effects of CD14 and LBP on LPS-host cell interactions.","volume":"11","author":"Kitchens","year":"2005","journal-title":"J Endotoxin Res"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":". Plasma levels of soluble CD14 independently predict mortality in HIV infection.","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0b013e3182745ab0","article-title":". Low level HIV viremia is associated with microbial translocation and inflammation.","volume":"62","author":"Reus","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","article-title":". Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS One"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/QAD.0b013e328339e228","article-title":". Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T cell activation following therapy.","volume":"24","author":"Wallet","year":"2010","journal-title":"AIDS"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/597476","article-title":". Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.","volume":"199","author":"Jiang","year":"2009","journal-title":"J Infect Dis"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JCM.01018-11","article-title":". Novel sensitive real-rime PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation.","volume":"49","author":"Kramski","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/QAD.0b013e32833ac623","article-title":". Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection.","volume":"24","author":"Rempel","year":"2010","journal-title":"AIDS"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/651430","article-title":". Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.","volume":"201","author":"Nowroozalizadeh","year":"2010","journal-title":"J Infect Dis"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/655229","article-title":". Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.","volume":"202","author":"Cassol","year":"2010","journal-title":"J Infect Dis"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1073\/pnas.0901983106","article-title":". Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.","volume":"106","author":"Redd","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/524143","article-title":". Relationship between T cell activation and CD4 T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.","volume":"197","author":"Hunt","year":"2008","journal-title":"J Infect Dis"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAD.0b013e32831e9c76","article-title":". Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.","volume":"23","author":"Papasavvas","year":"2009","journal-title":"AIDS"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/infdis\/jir559","article-title":". Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrums in HIV-infected patients with suboptimal CD4 T-cell response: a randomized controlled trial.","volume":"204","author":"Byakwaga","year":"2011","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31829a2f12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:02:27Z","timestamp":1620972147000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201310010-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31829a2f12","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}